Duearity AB (publ) (DEAR.ST)
SEK 0.02
(0.0%)
SEK 0.02
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 17.53 Million SEK | 192.56% |
| 2022 | 5.99 Million SEK | 18.73% |
| 2021 | 5.04 Million SEK | 762.71% |
| 2020 | 585 Thousand SEK | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 22.37 Million SEK | 27.62% |
| 2024 Q1 | 17.53 Million SEK | 0.03% |
| 2023 Q3 | 13.3 Million SEK | 56.87% |
| 2023 FY | 17.53 Million SEK | 192.56% |
| 2023 Q1 | 3.75 Million SEK | -37.3% |
| 2023 Q2 | 8.48 Million SEK | 125.74% |
| 2023 Q4 | 17.53 Million SEK | 31.76% |
| 2022 Q3 | 3.31 Million SEK | -45.07% |
| 2022 Q4 | 5.99 Million SEK | 81.03% |
| 2022 FY | 5.99 Million SEK | 18.73% |
| 2022 Q2 | 6.02 Million SEK | -0.76% |
| 2022 Q1 | 6.07 Million SEK | 20.31% |
| 2021 Q1 | 2.52 Million SEK | 0.0% |
| 2021 FY | 5.04 Million SEK | 762.71% |
| 2021 Q2 | 3.68 Million SEK | 46.29% |
| 2021 Q4 | 5.04 Million SEK | 55.29% |
| 2021 Q3 | 3.25 Million SEK | -11.88% |
| 2020 FY | 585 Thousand SEK | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acarix AB (publ) | 10.99 Million SEK | -59.393% |
| ADDvise Group AB (publ) | 2.67 Billion SEK | 99.344% |
| ADDvise Group AB (publ) | 2.67 Billion SEK | 99.344% |
| Arcoma AB | 33.3 Million SEK | 47.365% |
| Bactiguard Holding AB (publ) | 329.7 Million SEK | 94.683% |
| BICO Group AB (publ) | 3.26 Billion SEK | 99.463% |
| Boule Diagnostics AB (publ) | 279.9 Million SEK | 93.737% |
| CellaVision AB (publ) | 212.32 Million SEK | 91.744% |
| Clinical Laserthermia Systems AB (publ) | 14.19 Million SEK | -23.477% |
| Chordate Medical Holding AB (publ) | 6.86 Million SEK | -155.207% |
| C-Rad AB (publ) | 122.4 Million SEK | 85.678% |
| Dignitana AB (publ) | 37.56 Million SEK | 53.337% |
| Episurf Medical AB (publ) | 19.8 Million SEK | 11.465% |
| Getinge AB (publ) | 24.69 Billion SEK | 99.929% |
| Scandinavian Real Heart AB (Publ) | 20.6 Million SEK | 14.904% |
| Iconovo AB (publ) | 14.55 Million SEK | -20.449% |
| Integrum AB (publ) | 22.07 Million SEK | 20.581% |
| Luxbright AB (publ) | 7 Million SEK | -150.424% |
| Mentice AB (publ) | 163.55 Million SEK | 89.282% |
| OssDsign AB (publ) | 105.25 Million SEK | 83.346% |
| Paxman AB (publ) | 44.5 Million SEK | 60.615% |
| Promimic AB (publ) | 16.15 Million SEK | -8.505% |
| Qlife Holding AB (publ) | 62.16 Million SEK | 71.803% |
| SciBase Holding AB (publ) | 21.27 Million SEK | 17.614% |
| ScandiDos AB (publ) | 37.18 Million SEK | 52.859% |
| Sectra AB (publ) | 1.64 Billion SEK | 98.932% |
| Sedana Medical AB (publ) | 44.06 Million SEK | 60.215% |
| Senzime AB (publ) | 58.06 Million SEK | 69.81% |
| SpectraCure AB (publ) | 14.97 Million SEK | -17.062% |
| Stille AB | 172.64 Million SEK | 89.846% |
| Vitrolife AB (publ) | 3.66 Billion SEK | 99.522% |
| Xvivo Perfusion AB (publ) | 250.56 Million SEK | 93.004% |